Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.850
+0.040 (2.21%)
Nov 28, 2025, 1:00 PM EST - Market closed
Bionano Genomics Market Cap
Bionano Genomics has a market cap or net worth of $18.83 million as of November 28, 2025. Its market cap has decreased by -25.88% in one year.
Market Cap
18.83M
Enterprise Value
14.44M
1-Year Change
-25.88%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since September 21, 2018, Bionano Genomics's market cap has decreased from $66.34M to $18.83M, a decrease of -71.62%. That is a compound annual growth rate of -16.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 18.83M | -36.00% |
| Dec 31, 2024 | 29.41M | -59.93% |
| Dec 29, 2023 | 73.41M | -83.07% |
| Dec 30, 2022 | 433.51M | -49.86% |
| Dec 31, 2021 | 864.66M | 83.26% |
| Dec 31, 2020 | 471.81M | 1,336.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |